CA2650422A1 — Process for producing polymer micelles encapsulating low molecular weight drugs
Assigned to NanoCarrier Co Ltd · Expires 2007-11-08 · 19y expired
What this patent protects
A method of encapsulating a low molecular chemical in a polymer micelle which comprises the following steps: (a) dissolving or dispersing the above-described chemical, which has been electrically charged, in an aqueous medium; (b) preparing an aqueous medium containing the polyme…
USPTO Abstract
A method of encapsulating a low molecular chemical in a polymer micelle which comprises the following steps: (a) dissolving or dispersing the above-described chemical, which has been electrically charged, in an aqueous medium; (b) preparing an aqueous medium containing the polymer micelle as described above which comprises an area having a hydrophobic side chain and a side chain charged oppositely to the low molecular chemical distributed at random and being hydrophobic as a whole and a hydrophilic area; (c) mixing the aqueous medium having the low molecular chemical dissolved or dispersed therein with the aqueous medium containing the polymer micelle; and (d) adjusting the aqueous medium mixture thus obtained to a pH value at which the encapsulation of the low molecular chemical is stabilized.
Drugs covered by this patent
- Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.